Remodeling tumor‐associated macrophage for anti‐cancer effects by rational design of irreversible inhibition of mitogen‐activated protein kinase‐activated protein kinase 2

Documenti analoghi

• Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4
  di: Jiangchun Wu, et al.
  Pubblicazione: (2024)
• Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
  di: Xuejin Ou, et al.
  Pubblicazione: (2024)
• Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor‐mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation
  di: Fuyan Xu, et al.
  Pubblicazione: (2024)
• Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
  di: Changping Deng, et al.
  Pubblicazione: (2025)
• Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
  di: Tian‐Hua Wei, et al.
  Pubblicazione: (2024)